Ken Shadlen

  • Permalink Gallery

    Brazil’s Fight against Hepatitis C — Universalism, Local Production, and Patents

Brazil’s Fight against Hepatitis C — Universalism, Local Production, and Patents

In his recent short essay for the New England Journal of Medicine, Professor Ken Shadlen and co-authors examine three aspects of Brazili’s pioneering approach to the treatment of Hepatitis C virus (HCV). 

Brazil has been a pioneer in AIDS treatment, expanding access to key drugs and care. It has served as a model for other developing countries, showing that prevention and […]

February 14th, 2019|Featured, Publications|0 Comments|

The Future of AIDS Treatment: A Commentary

Professor Ken Shadlen provides a short commentary on Laurie Garrett’s short essay on the future of the AIDS pandemic, “Welcome to the Next Deadly AIDS Pandemic,” which was published in Foreign Policy last week.

As of 2000, less than five percent of people with HIV/AIDS in developing countries received treatment. Now, substantially greater than 50 percent receive antiretroviral therapy. What was a […]

  • Permalink Gallery

    Indian pharmaceutical patent prosecution: The changing role of Section 3(d)

Indian pharmaceutical patent prosecution: The changing role of Section 3(d)

Professor Kenneth Shadlen (LSE) and Dr Bhaven Sampat (Columbia University) have a new article on pharmaceutical patenting in India:

As elsewhere in the developing world, pharmaceutical patents are new in India, introduced because required by the World Trade Organization. India’s patent law includes a provision, Section 3(d), which tries to limit grant of “secondary” pharmaceutical patents, i.e. patents on new forms […]

The Problem with Trump’s “Protectionism”

President Trump announced that the US would apply tariffs of 10 percent and 25 percent on all imports of aluminium and steel, respectively. The announcement has been derided for being “protectionist” and damaging to the US economy, and likely to trigger a global “trade war.” Professor Ken Shadlen’s concerns lie elsewhere; the measures’ likely effects on the US economy can […]

  • Permalink Gallery

    Book Review: Coalitions and Compliance: The Political Economy of Pharmaceutical Patents in Latin America

Book Review: Coalitions and Compliance: The Political Economy of Pharmaceutical Patents in Latin America

In Coalitions and Compliance, Kenneth Shadlen, Professor of Development Studies and Head of Department in the Department of International Development, examines how international changes can reconfigure domestic politics. The book presents global changes in intellectual property, particularly regarding pharmaceutical patents, and the ensuing challenges for developing countries through a systematic comparative analysis of pharmaceutical patent politics in Latin America’s three largest countries […]

  • Permalink Medicine Pills Pill Treatment RemedyGallery

    Promoting and Regulating Generic Medicines: Brazil in Comparative Perspective

Promoting and Regulating Generic Medicines: Brazil in Comparative Perspective

In a recent publication, Professor Ken Shadlen (along with Elize Fonseca), uses Brazil as a case study for a suggested typology to compare national approaches towards the promotion and regulation of generic drugs.  

Differences in countries’ practices with regard to “generic” drug regulation can have far-reaching implications on the supply of medicines and health outcomes. Generic drug regulations can promote (or restrict) competition and […]

Market Access and the EU Referendum

In light of the upcoming EU Referendum Professor Ken Shadlen sheds some light on the implications for Britain’s trade.

I’ve read and heard lots of discussions about the referendum and implications for Britain’s trade, most of it misleading and incorrect. Let me try to simplify (it sounds more confusing than it is):

On any given product, countries have two tariffs, one […]

Drug patenting in India – Ken Shadlen

Kenneth C. Shadlen and Bhaven N. Sampat, ‘Drug patenting in India: Looking back and looking forward’, Nature Reviews Drug Discovery, 14: 519-520. DOI: 10.1038/nrd4681 This open-access article is one of a series of papers Bhaven Sampat and I are writing as part of our ESRC-funded research on pharmaceutical patenting in the developing world. In this paper we sought to contrast two different explanations for […]

  • Permalink Gallery

    Book Launch – Private Wealth and Public Revenue in South America

Book Launch – Private Wealth and Public Revenue in South America

The launch event for Dr Tasha Fairfield’s new book, Private Wealth and Public Revenue in Latin America, will take place next Wednesday (13th May) at 18:30 in 32L.G.03 (Lincoln’s Inn Fields).

About the book:

Inequality and taxation are fundamental problems of modern times. How and when can democracies tax economic elites? This book develops a theoretical framework that refines and integrates […]

Ken Shadlen wins Open Article prize for 2014

Ken Shadlen, along with Mark Manger (formerly of LSE), has been awarded the Open Article prize for 2014 from the Economics and Politics Section of the Latin American Studies Association. Their prizewinning paper, ‘Political Trade Dependence and North–South Trade Agreements’, was published in the International Studies Quarterly journal in March last year (full citation below). The research was funded by the […]